Abstract: Compounds, compositions and methods are provided that are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. In particular, the compounds of the invention are useful in the treatment and/or prevention of eating disorders, obesity, anxiety disorders and mood disorders.

Abstract: A method, terminal device, network element, system and computer program product for controlling discontinuous reception or transmission at a terminal device of a communication network are disclosed. A regular discontinuous reception or transmission cycle of a regular discontinuous reception or transmission scheme is set by using a first control layer, and in addition thereto a shorter temporary discontinuous reception or transmission cycle of an interim discontinuous reception or transmission scheme can be set by using a second control layer. This arrangement provides long discontinuous reception or transmission cycles for power consumption improvements while at the same time ensuring that the network can easily and flexibly shorten these cycles for increased data throughput, if needed.

Abstract: The present invention is a method for adjusting power consumption in a network system including a first communication device and a second communication device communicating with the first communication device, wherein the method includes the first communication device creating IC operation information related to the operation of a first information processing IC in the first communication device and sending the IC operation information to the second communication device; the second communication device acknowledging the sent IC operation information in whole or in part and sending the acknowledged IC operation information to the first communication device; and the first communication device adjusting the driving frequency and/or the supply voltage of the first information processing IC according to the acknowledged IC operation information.

Abstract: A new and unique method or apparatus for implementing an unscheduled automatic power save delivery (U-APSD) in a wireless local area network (WLAN) terminal, comprising maintaining a timer for defining a triggering interval between sending of subsequent trigger frames to a WLAN access point, wherein the value of the timer is set to dynamically change according to one or more criteria relating to the current communication situation. The criteria depend on whether there are buffered frames. at another node, point, terminal or device, such as an Access Point (AP)), in the wireless local area network (WLAN), or other suitable network. For example, when there are buffered frames at the AP, the WLAN terminal sets the triggering interval to a minimum value and sends null-data frames to quickly retrieve them, or when there is no buffered frame at the AP, the STA sets the triggering interval to a larger value to continue the doze mode for a long time and to save energy.

Abstract: Compounds, compositions and methods are provided that are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. In particular, the compounds of the invention are useful in the treatment and/or prevention of eating disorders, obesity, anxiety disorders and mood disorders.

Abstract: Compounds, compositions and methods are provided that are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. In particular, the compounds of the invention are useful in the treatment and/or prevention of eating disorders, obesity, anxiety disorders and mood disorders.

Abstract: Compounds, compositions and methods are provided that are useful in the treatment or prevention of conditions or disorders associated with a neuropeptide receptor. The subject methods are particularly useful in the treatment and/or prevention of endocrine, metabolic, cardiovascular, neurologic, psychiatric, gastrointestinal, genitourinary and other disorders.

Abstract: Hydroxyamidines and related compounds are provided which are suitable as antibacterial agents.

Abstract: Hydroxyamidines and related compounds are provided which are suitable as antibacterial agents.

Abstract: The present invention provides compounds having the formula: wherein R1, R2, R, R? and the subscript p are described herein. The compounds are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. Pharmaceutical compositions and methods of using these compounds for the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor, such as eating disorder, obesity, anxiety disorders and mood disorders are also provided.

Abstract: The present invention relates to the compounds of Formula I, their preparation and pharmaceutical compositions comprising them. The compounds and pharmaceutical compositions are useful, for example, for the treatment and prevention of obesity, obesity-related disorders and eating disorders.

Abstract: A method for combating the tracking of a mobile transceiver, the mobile transceiver forming a node in a wireless communication network which has at least one other node, the method comprising the steps for enabling, until a first time, the transmission of a radio packet that depends upon a first anonymous address; calculating, dependent on a privacy level for the mobile transceiver, a second time; enabling, from the second time, the transmission of a radio packet that depends upon a second anonymous address; and disabling, between the first time and the second time, the transmission of a radio packet that depends upon either the first anonymous address or the second anonymous address.

Abstract: Hydroxyamidines and related compounds are provided which are suitable as antibacterial agents.

Abstract: Compounds, compositions and methods are provided that are useful in the treatment or prevention of conditions or disorders associated with a neuropeptide receptor. The subject methods are particularly useful in the treatment and/or prevention of endocrine, metabolic, cardiovascular, neurologic, psychiatric, gastrointestinal, genitourinary and other disorders.

Abstract: Improved endpoint detection is obtained for wet etch and/or other chemical processes involving in situ measurement of bath impedance. The endpoint detection uses a measurement apparatus having a measurement circuit with a capacitor designed to alter the phase angle of the circuit. The capacitor is preferably a variable capacitor which is used to set the initial phase angle of the measurement circuit to about zero. The methods using the improved detection enable etch to be more precisely controlled even under conditions where noise would otherwise adversely impact determination of the endpoint.

Abstract: A method for manufacturing a workpiece and a torque transducer module for material removal techniques, are disclosed, where machining friction varies in dependency of machining depth and the torque/deformation of a shaft is monitored for controlling material removal. The module has a body extending along a central axis and two end portions. Each end portion is part of an axial mount for a respective part to be axially mounted thereto. The module also includes a strain gage sensor arrangement with at least one electric output.

Abstract: A method for combating the tracking of a mobile transceiver, comprising at the mobile transceiver: enabling, until a first time, the transmission of a radio packet that depends upon a first anonymous address; enabling, from a second time, the transmission of a radio packet that depends upon a second anonymous address; and disabling, between the first time and the second time, the transmission of a radio packet that depends upon either the first anonymous address or the second anonymous address. Also described is a method for combating the tracking of a mobile transceiver, comprising at the mobile transceiver: transmitting, until a first time, radio packets that depend upon a first anonymous address; transmitting, from a second time, radio packets that depend upon a second anonymous address; and transmitting, between the first time and the second time, radio packets that depend on neither the first anonymous address nor the second anonymous address.

Abstract: Compounds, compositions and methods are provided that are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. In particular, the compounds of the invention are useful in the treatment and/or prevention of eating disorders, obesity, anxiety disorders and mood disorders.

Abstract: A method for reducing interference between a first frequency-hopping radio communications network and a second frequency-hopping radio communications network, comprising: predicting a possible collision between a transmission at a first frequency in the first frequency-hopping radio communication network and a transmission at the first frequency in the second frequency-hopping radio communication network; and controlling transmission in one of the first frequency-hopping radio communications network and the second frequency-hopping radio communications network to avoid the collision.

Abstract: A node selecting method is characterized by comprising a first step of reserving a communication band on a route by seeking a communication route from a source node to a destination node through intermediate nodes by use of an ad-hoc on-demand distance vector (AODV) algorithm in a mobile ad-hoc network; a second step of storing information on communication bandwidth of a link route connecting each pair of neighboring intermediate nodes on the communication route in the intermediate nodes; and a third step of collecting information on available communication bandwidth of the communication route and transmitting it to the source node when a route reply is made from the destination node on the communication route toward the source node.